Fazio, Sergio
OHSU School of Medicine,
United States
2025 Rank: 73720
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1834 out of 235606 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 73720 | 82019 |
| Total Cites | 2151 | 2288 |
| H-index | 17 | 17 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 46 | 46 |
| Number of Single+First+Last Authored Papers | 157 | 157 |
| Total Cites to Single+First+Last Authored Papers | 345 | 352 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1775 | 1860 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.23 |
| Self-Citation Percentage |
5.99%
|
|
Fazio, Sergio
Regeneron Pharmaceuticals, Inc.,
United States
2024 Rank: 60929
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1622 out of 224060 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 60929 | 65852 |
| Total Cites | 1988 | 2122 |
| H-index | 17 | 18 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 41 | 43 |
| Number of Single+First+Last Authored Papers | 155 | 155 |
| Total Cites to Single+First+Last Authored Papers | 349 | 359 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1633 | 1721 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.23 |
| Self-Citation Percentage |
6.31%
|
|
Fazio, Sergio
Regeneron Pharmaceuticals, Inc.,
United States
2023 Rank: 44993
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1328 out of 210400 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 44993 | 50047 |
| Total Cites | 2110 | 2275 |
| H-index | 18 | 19 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 42 | 44 |
| Number of Single+First+Last Authored Papers | 155 | 155 |
| Total Cites to Single+First+Last Authored Papers | 426 | 445 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1686 | 1777 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.28 |
| Self-Citation Percentage |
7.25%
|
|
Fazio, Sergio
OHSU School of Medicine,
United States
2022 Rank: 45929
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1352 out of 199278 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 45929 | 49960 |
| Total Cites | 1785 | 1962 |
| H-index | 18 | 18 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 48 | 50 |
| Number of Single+First+Last Authored Papers | 145 | 145 |
| Total Cites to Single+First+Last Authored Papers | 358 | 388 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1429 | 1513 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.30 |
| Self-Citation Percentage |
9.02%
|
|
Fazio, Sergio
OHSU School of Medicine,
United States
2021 Rank: 44772
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1274 out of 192021 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 44772 | 48506 |
| Total Cites | 2574 | 2888 |
| H-index | 22 | 23 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 75 | 80 |
| Number of Single+First+Last Authored Papers | 141 | 141 |
| Total Cites to Single+First+Last Authored Papers | 536 | 583 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2104 | 2258 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.28 |
| Self-Citation Percentage |
10.87%
|
|
Fazio, Sergio
OHSU School of Medicine,
United States
2020 Rank: 72041
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Cardiovascular System & Hematology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1912 out of 152312 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 72041 | 76755 |
| Total Cites | 1892 | 2145 |
| H-index | 19 | 20 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 55 | 60 |
| Number of Single+First+Last Authored Papers | 136 | 136 |
| Total Cites to Single+First+Last Authored Papers | 407 | 451 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1528 | 1656 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.30 |
| Self-Citation Percentage |
11.79%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.